Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MULTICENTER DOUBLE-BLIND' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 57 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Emre, M; Qizilbash, N
      Experimental approaches and drugs in development for the treatment of dementia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    2. Diener, HC; Limmroth, V
      Advances in pharmacological treatment of migraine

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    3. Fritze, J; Moller, HJ
      Design of clinical trials of antidepressants - Should a placebo control arm be included?

      CNS DRUGS
    4. Solai, LKK; Mulsant, BH; Pollock, BG
      Selective serotonin reuptake inhibitors for late-life depression - A comparative review

      DRUGS & AGING
    5. Fetrow, CW; Avila, JR
      Efficacy of the dietary supplement S-adenosyl-L-methionine

      ANNALS OF PHARMACOTHERAPY
    6. Clase, CM; Crowther, MA; Ingram, AJ; Cina, CS
      Thrombolysis for restoration of patency to haemodialysis central venous catheters: A systematic review

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    7. Montgomery, SA
      A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    8. Crone, C; Gabriel, G; Wise, TN
      Non-herbal nutritional supplements - The next wave - A comprehensive review of risks and benefits for the C-L psychiatrist

      PSYCHOSOMATICS
    9. Hurst, M; Jarvis, B
      Perindopril - An updated review of its use in hypertension

      DRUGS
    10. Barbui, C; Hotopf, M
      Amitriptyline v. the rest: still the leading antidepressant after 40 yearsof randomised controlled trials

      BRITISH JOURNAL OF PSYCHIATRY
    11. Katona, C
      Managing depression and anxiety in the elderly patient

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    12. Anderson, IM
      Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability

      JOURNAL OF AFFECTIVE DISORDERS
    13. Bondareff, W; Alpert, M; Friedhoff, AJ; Richter, EM; Clary, CM; Batzar, E
      Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life

      AMERICAN JOURNAL OF PSYCHIATRY
    14. Szabadi, E; Tavernor, S
      Hypo- and hypersalivation induced by psychoactive drugs - Incidence, mechanisms and therapeutic implications

      CNS DRUGS
    15. Gerson, S; Belin, TR; Kaufman, A; Mintz, J; Jarvik, L
      Pharmacological and psychological treatments for depressed older patients:A meta-analysis and overview of recent findings

      HARVARD REVIEW OF PSYCHIATRY
    16. Lotufo-Neto, F; Trivedi, M; Thase, ME
      Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression

      NEUROPSYCHOPHARMACOLOGY
    17. McCarty, MF; Russell, AL
      Niacinamide therapy for osteoarthritis - does it inhibit nitric oxide synthase induction by interleukin-1 in chondrocytes?

      MEDICAL HYPOTHESES
    18. Lapierre, YD; Angus, C; Awad, AG; Saxena, BM; Jones, B; Williamson, P; Vincent, P; Carle, R; Lavallee, YJ; Manchanda, R; Gauthier, B; Wolf, MA; Teehan, MD; Denis, JF; Malla, AK; Oyewumi, LK; Busse, E; Labelle, A; Claesson, L; Grafford, K
      The treatment of negative symptoms: a clinical and methodological study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    19. Mendlewicz, J
      Predicting response: serotonin reuptake inhibition

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    20. DASGUPTA K
      TREATMENT OF DEPRESSION IN ELDERLY PATIENTS - RECENT ADVANCES

      Archives of family medicine
    21. HASSELBLAD V
      METAANALYSIS OF MULTITREATMENT STUDIES

      Medical decision making
    22. DUNNER D; KUMAR R
      PAROXETINE - A REVIEW OF CLINICAL-EXPERIENCE

      Pharmacopsychiatry
    23. MOURILHE P; STOKES PE
      RISKS AND BENEFITS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN THE TREATMENT OF DEPRESSION

      Drug safety
    24. DIENER HC; KAUBE HE; LIMMROTH V
      A PRACTICAL GUIDE TO THE MANAGEMENT AND PREVENTION OF MIGRAINE

      Drugs
    25. RICHARDSON P; HAWKEY CJ; STACK WA
      PROTON PUMP INHIBITORS - PHARMACOLOGY AND RATIONALE FOR USE IN GASTROINTESTINAL DISORDERS

      Drugs
    26. GUNASEKARA NS; NOBLE S; BENFIELD P
      PAROXETINE - AN UPDATE OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN DEPRESSION AND A REVIEW OF ITS USE IN OTHER DISORDERS

      Drugs
    27. KANOWSKI S; HERRMANN WM; STEPHAN K; WIERICH W; HORR R
      PROOF OF EFFICACY OF THE GINKGO-BILOBA SPECIAL EXTRACT EGB-761 IN OUTPATIENTS SUFFERING FROM MILD-TO-MODERATE PRIMARY DEGENERATIVE DEMENTIAOF THE ALZHEIMER-TYPE OR MULTIINFARCT DEMENTIA (REPRINTED FROM PHARMACOPSYCHIAT, VOL 29, PG 47-56, 1996)

      Phytomedicine
    28. GASBARRINI G; STEFANINI G; ADDOLORATO G; FOSCHI F; RICCI C; BERTOLOTTI P; VOLTOLINI G; BONAVITA E; BERTONCELLI R; RENZI G; BIANCHINI G; BONAIUTO S; GIANNANDREA E; CAVASSINI G; MAZZINI V; CHIOMA V; MARZARA G; DADDETTA G; TOTARO G; DALMONTE E; TASSINI D; GIUNGI F; DENITTO C; DIFAZIO G; TESSITORE A; GUADAGNINO M; TESSITORE E; SPINA P; LUPPI M; BIGNAMINI A; PERACINO L; FIORENTINO M; BEUNGARBE D; POLI A; AMBROSOLI L; GIRARDELLO R
      POSATIRELIN FOR THE TREATMENT OF DEGENERATIVE AND VASCULAR DEMENTIA -RESULTS OF EXPLANATORY AND PRAGMATIC EFFICACY ANALYSES

      Archives of gerontology and geriatrics
    29. MITTMANN N; HERRMANN N; EINARSON TR; BUSTO UE; LANCTOT KL; LIU BA; SHULMAN KI; SILVER IL; NARANJO CA; SHEAR NH
      THE EFFICACY, SAFETY AND TOLERABILITY OF ANTIDEPRESSANTS IN LATE-LIFEDEPRESSION - A METAANALYSIS

      Journal of affective disorders
    30. HOTOPF M; HARDY R; LEWIS G
      DISCONTINUATION RATES OF SSRIS AND TRICYCLIC ANTIDEPRESSANTS - A METAANALYSIS AND INVESTIGATION OF HETEROGENEITY

      British Journal of Psychiatry
    31. SCHNEIDER LS
      PHARMACOLOGICAL CONSIDERATIONS IN THE TREATMENT OF LATE-LIFE DEPRESSION

      The American journal of geriatric psychiatry
    32. MERCHANT KM; FIGUR LM; EVANS DL
      INDUCTION OF C-FOS MESSENGER-RNA IN RAT MEDIAL PREFRONTAL CORTEX BY ANTIPSYCHOTIC-DRUGS - ROLE OF DOPAMINE D2 AND D3 RECEPTORS

      Cerebral cortex
    33. SCHNYDER U
      SUDDEN RECOVERY FROM DEPRESSION UNDER TREATMENT WITH PAROXETINE

      The European journal of psychiatry
    34. DIMARIO F; BATTAGLIA G; LEANDRO G; GRASSO G; VIANELLO F; VIGNERI S
      SHORT-TERM TREATMENT OF GASTRIC-ULCER - A META-ANALYTICAL EVALUATION OF BLIND TRIALS

      Digestive diseases and sciences
    35. KIM KY; MCCARTNEY JR; KAYE W; BOLAND RJ; NIAURA R
      THE EFFECT OF CIMETIDINE AND RANITIDINE ON COGNITIVE FUNCTION IN POSTOPERATIVE CARDIAC SURGICAL PATIENTS

      International journal of psychiatry in medicine
    36. AVEDISOVA AS
      THE APPLICATION OF AMITRIPTYLINE ANALOG-A MIZOLE IN DEPRESSIONS

      Zurnal nevropatologii i psihiatrii im. S.S. Korsakova
    37. FULTON B; BENFIELD P
      MOCLOBEMIDE - AN UPDATE OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE

      Drugs
    38. OWENS DGC
      ADVERSE-EFFECTS OF ANTIPSYCHOTIC AGENTS - DO NEWER AGENTS OFFER ADVANTAGES

      Drugs
    39. CHRISTIANSEN PE; BEHNKE K; BLACK CH; OHRSTROM JK; BORKRASMUSSEN H; NILSSON J
      PAROXETINE AND AMITRIPTYLINE IN THE TREATMENT OF DEPRESSION IN GENERAL-PRACTICE

      Acta psychiatrica Scandinavica
    40. RIEDEL WJ; VANPRAAG HM
      AVOIDING AND MANAGING ANTICHOLINERGIC EFFECTS OF ANTIDEPRESSANTS

      CNS DRUGS
    41. ANDERSON IM; TOMENSON BM
      TREATMENT DISCONTINUATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS COMPARED WITH TRICYCLIC ANTIDEPRESSANTS - A METAANALYSIS

      BMJ. British medical journal
    42. KASPER S; HEIDEN A
      DO SSRIS DIFFER IN THEIR ANTIDEPRESSANT EFFICACY

      Human psychopharmacology
    43. MONTGOMERY SA; KASPER S
      COMPARISON OF COMPLIANCE BETWEEN SEROTONIN REUPTAKE INHIBITORS AND TRICYCLIC ANTIDEPRESSANTS - A METAANALYSIS

      International clinical psychopharmacology
    44. RAMMSAYER T; GALLHOFER B
      REMOXIPRIDE VERSUS HALOPERIDOL IN HEALTHY-VOLUNTEERS - PSYCHOMETRIC PERFORMANCE AND SUBJECTIVE TOLERANCE PROFILES

      International clinical psychopharmacology
    45. KLINKENBERGKNOL EC; FESTEN HPM; MEUWISSEN SGM
      PHARMACOLOGICAL MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE

      Drugs
    46. PAYKEL ES
      CLINICAL EFFICACY OF REVERSIBLE AND SELECTIVE INHIBITORS OF MONOAMINE-OXIDASE-A IN MAJOR DEPRESSION

      Acta psychiatrica Scandinavica
    47. MORTIMER AM
      NEWER AND OLDER ANTIPSYCHOTICS - A COMPARATIVE REVIEW OF APPROPRIATE USE

      CNS DRUGS
    48. KRUGER K; SCHATTENKIRCHNER M
      COMPARISON OF CYCLOSPORINE-A AND AZATHIOPRINE IN THE TREATMENT OF RHEUMATOID-ARTHRITIS - RESULTS OF A DOUBLE-BLIND MULTICENTER STUDY

      Clinical rheumatology
    49. PFAFFENRATH V; DIENER HC; ISLER H; MEYER C; SCHOLZ E; TANERI Z; WESSELY P; ZAISERKASCHEL H; HAASE W; FISCHER W
      EFFICACY AND TOLERABILITY OF AMITRIPTYLINOXIDE IN THE TREATMENT OF CHRONIC TENSION-TYPE HEADACHE - A MULTICENTER CONTROLLED-STUDY

      Cephalalgia
    50. ANDERSON IM; TOMENSON BM
      THE EFFICACY OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN DEPRESSION- A METAANALYSIS OF STUDIES AGAINST TRICYCLIC ANTIDEPRESSANTS

      JOURNAL OF PSYCHOPHARMACOLOGY
    51. DEBOER WA; TYTGAT GNJ
      DRUG-THERAPY FOR REFLUX ESOPHAGITIS

      Alimentary pharmacology & therapeutics
    52. DEUTCH AY
      IDENTIFICATION OF THE NEURAL SYSTEMS SUBSERVING THE ACTIONS OF CLOZAPINE - CLUES FROM IMMEDIATE-EARLY GENE-EXPRESSION

      The Journal of clinical psychiatry
    53. KOELZ HR
      TREATMENT OF GASTROESOPHAGEAL REFLUX DISE ASE

      Schweizerische medizinische Wochenschrift
    54. DEUTCH AY
      PREFRONTAL CORTICAL DOPAMINE SYSTEMS AND THE ELABORATION OF FUNCTIONAL CORTICOSTRIATAL CIRCUITS - IMPLICATIONS FOR SCHIZOPHRENIA AND PARKINSONS-DISEASE

      Journal of neural transmission
    55. ALEXANDER MS; CHAKRAVARTI SK; SUNDARARAJAN K; MULLIN JM; SHAW SH; BLOMQVIST M; LOCKETT CM
      ONCE-DAILY CONTROLLED-RELEASE REMOXIPRIDE IS EQUIEFFECTIVE WITH TWICE-DAILY IMMEDIATE-RELEASE REMOXIPRIDE IN THE TREATMENT OF SCHIZOPHRENIA

      JOURNAL OF PSYCHOPHARMACOLOGY
    56. MELTZER HY
      NEW DRUGS FOR THE TREATMENT OF SCHIZOPHRENIA

      The Psychiatric clinics of North America
    57. FELDMAN M
      PROS AND CONS OF OVER-THE-COUNTER AVAILABILITY OF HISTAMINE(2)-RECEPTOR ANTAGONISTS

      Archives of internal medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/02/20 alle ore 10:53:01